ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,467 | -31.6% | 6,072 | -11.5% | 0.13% | -30.3% |
| Q2 2023 | $316,452 | +16.4% | 6,860 | +1.2% | 0.19% | +26.2% |
| Q1 2023 | $271,758 | -11.9% | 6,777 | +1.8% | 0.15% | -7.5% |
| Q4 2022 | $308,326 | +49.7% | 6,655 | +34.0% | 0.16% | +96.3% |
| Q3 2022 | $206,000 | -29.5% | 4,965 | +1.4% | 0.08% | -24.1% |
| Q2 2022 | $292,000 | -11.5% | 4,895 | +7.6% | 0.11% | -27.0% |
| Q1 2022 | $330,000 | -13.8% | 4,550 | 0.0% | 0.15% | +2.1% |
| Q4 2021 | $383,000 | -4.5% | 4,550 | +2.2% | 0.14% | -17.6% |
| Q3 2021 | $401,000 | -13.4% | 4,450 | -8.3% | 0.18% | -7.4% |
| Q2 2021 | $463,000 | -0.4% | 4,853 | +18.7% | 0.19% | -3.1% |
| Q1 2021 | $465,000 | -15.5% | 4,087 | +2.9% | 0.20% | -14.0% |
| Q4 2020 | $550,000 | -22.1% | 3,972 | -53.7% | 0.23% | -38.4% |
| Q3 2020 | $706,000 | +14.8% | 8,587 | +9.2% | 0.37% | +27.1% |
| Q2 2020 | $615,000 | +0.5% | 7,864 | -42.9% | 0.29% | +15.5% |
| Q1 2020 | $612,000 | -4.1% | 13,774 | -7.8% | 0.25% | +142.3% |
| Q4 2019 | $638,000 | +23.2% | 14,936 | +23.3% | 0.10% | 0.0% |
| Q3 2019 | $518,000 | -42.4% | 12,118 | -14.4% | 0.10% | -45.3% |
| Q2 2019 | $899,000 | -20.9% | 14,162 | -13.6% | 0.19% | -92.1% |
| Q1 2019 | $1,136,000 | +98.6% | 16,385 | +24.6% | 2.42% | +2366.3% |
| Q4 2018 | $572,000 | -20.7% | 13,150 | +39.3% | 0.10% | +30.7% |
| Q3 2018 | $721,000 | +6.7% | 9,441 | +7.4% | 0.08% | -87.5% |
| Q2 2018 | $676,000 | -21.9% | 8,794 | -48.2% | 0.60% | -20.4% |
| Q1 2018 | $866,000 | +136.6% | 16,983 | +115.2% | 0.75% | +63.6% |
| Q4 2017 | $366,000 | +28.4% | 7,893 | +47.7% | 0.46% | +1107.9% |
| Q3 2017 | $285,000 | -5.6% | 5,343 | +10.1% | 0.04% | -15.6% |
| Q2 2017 | $302,000 | +12.3% | 4,855 | +22.2% | 0.04% | -6.2% |
| Q1 2017 | $269,000 | +6.7% | 3,972 | +10.6% | 0.05% | -36.0% |
| Q4 2016 | $252,000 | -12.2% | 3,591 | -11.3% | 0.08% | -46.0% |
| Q3 2016 | $287,000 | +44.9% | 4,050 | 0.0% | 0.14% | -5.4% |
| Q2 2016 | $198,000 | +30.3% | 4,050 | +68.5% | 0.15% | -29.7% |
| Q1 2016 | $152,000 | – | 2,404 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |